Literature DB >> 12430940

Treatment of polycythemia vera with recombinant interferon.

Richard T Silver1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12430940     DOI: 10.1007/bf03165137

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  14 in total

1.  Interferon-alpha-induced morphological changes of megakaryocytes: a histomorphometrical study on bone marrow biopsies in chronic myeloproliferative disorders with excessive thrombocytosis.

Authors:  A Chott; H Gisslinger; J Thiele; E Fritz; W Linkesch; T Radaszkiewicz; H Ludwig
Journal:  Br J Haematol       Date:  1990-01       Impact factor: 6.998

2.  Acute leukemia and myelodysplasia in polycythemia vera. A clinical study with long-term follow-up.

Authors:  Y Najean; A Deschamps; C Dresch; M T Daniel; J D Rain; J P Arrago
Journal:  Cancer       Date:  1988-01-01       Impact factor: 6.860

3.  Interferon inhibits the establishment of competence in Go/S-phase transition.

Authors:  S L Lin; T Kikuchi; W J Pledger; I Tamm
Journal:  Science       Date:  1986-07-18       Impact factor: 47.728

4.  Interferon-alpha 2b: a new treatment for polycythemia vera.

Authors:  R T Silver
Journal:  Ann Intern Med       Date:  1993-12-01       Impact factor: 25.391

5.  Hydroxyurea and sickle cell crisis.

Authors:  R T Silver
Journal:  N Engl J Med       Date:  1995-10-12       Impact factor: 91.245

6.  The very-long-term course of polycythaemia: a complement to the previously published data of the Polycythaemia Vera Study Group.

Authors:  Y Najean; C Dresch; J D Rain
Journal:  Br J Haematol       Date:  1994-01       Impact factor: 6.998

7.  Cerebral blood-flow in polycythaemia.

Authors:  D J Thomas; G H du Boulay; J Marshall; T C Pearson; R W Ross Russell; L Symon; G Wetherley-Mein; E Zilkha
Journal:  Lancet       Date:  1977-07-23       Impact factor: 79.321

8.  Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: prospective study of efficacy and leukaemogenicity with therapeutic implications.

Authors:  A Weinfeld; B Swolin; J Westin
Journal:  Eur J Haematol       Date:  1994-03       Impact factor: 2.997

9.  Polycythaemia vera in young people: an analysis of 58 cases diagnosed before 40 years.

Authors:  Y Najean; P Mugnier; C Dresch; J D Rain
Journal:  Br J Haematol       Date:  1987-11       Impact factor: 6.998

10.  Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.

Authors:  P D Berk; J D Goldberg; P B Donovan; S M Fruchtman; N I Berlin; L R Wasserman
Journal:  Semin Hematol       Date:  1986-04       Impact factor: 3.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.